Back
Alsea SAB de CV Vs. NovoCure Industry Stock Comparison
Sell
22
ALSSF
Alsea SAB de CV
Last Price:
$2.20
Seasonality Move:
8.35%
Sell
49
NVCR
NovoCure
Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
22
Alsea SAB de CV (ALSSF)
is a Sell
Is Alsea SAB de CV a Buy, Sell or Hold?
-
The current Alsea SAB de CV [ALSSF] share price is $2.20. The Score for ALSSF is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
ALSSF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALSSF Stock Price Chart
What is Alsea SAB de CV's stock price today?
-
The Alsea SAB de CV share price today is $2.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALSSF is experiencing slight buying pressure.
NVCR Stock Price Chart
ALSSF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 47.03 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.15 - 2.27) | Sell |
Bollinger Bands (100): | (2.29 - 2.83) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.94 | Buy |
Relative Strength Index (14 RSI): | 58.79 | Buy |
Chaikin Money Flow: | -60501 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.36 - 32.64) | Buy |
Bollinger Bands (100): | (14.38 - 25.86) | Buy |
ALSSF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.17 | Buy |
20-day SMA: | 2.21 | Sell |
50-day SMA: | 2.32 | Sell |
200-day SMA: | 3.22 | Sell |
8-day EMA: | 2.17 | Buy |
20-day EMA: | 2.21 | Sell |
50-day EMA: | 2.34 | Sell |
200-day EMA: | 2.91 | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.52 | Sell |
20-day SMA: | 30.41 | Sell |
50-day SMA: | 23.25 | Buy |
200-day SMA: | 18.89 | Buy |
8-day EMA: | 30.36 | Sell |
20-day EMA: | 29.22 | Buy |
50-day EMA: | 25.18 | Buy |
200-day EMA: | 21.21 | Buy |
Alsea SAB de CV Earnings Growth & ALSSF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.
Alsea SAB de CV Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |